Select a community
All Communities
Home > Community Treatment Reports > Zolpidem Treatment Report
What is Zolpidem?

Zolpidem tartrate is a sedative-hypnotic drug that is used for short-term treatment of insomnia that presents as difficulty of sleep onset and maintenance of sleep.

Side Effects

Side effects as an overall problem

Severe
25 8%
Moderate
46 15%
Mild
110 37%
None
117 39%

Most commonly reported side effects

Amnesia
41 27%
Grogginess
35 23%
Groggy in morning
29 19%
Drowsy in a.m.
28 19%
Sleep-related eating with amnesia
21 14%
Sleep walking (somnambulism)
20 13%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Zolpidem. See all 55 dosages

  0.5 10mg as needed 10 mg as needed 10mg as needed 12.5 mg all the time (24/7) 12.5 mg as needed 12.5mg as needed 12mg as needed 1mg as needed 20mg as needed 2 10mg as needed 2.5mg as needed 3.3 mg as needed 3mg as needed 40mg as needed 4mg as needed 50mg as needed 5 mg as needed 5mg as needed 6.25mg as needed 625mg as needed 6.5mg as needed 6mg as needed as needed daily mg as needed 0.12 mg daily 5 mg monthly 6.25 mg every other week 0.5 mg daily 10 mg every other week 5 mg weekly 1 mg daily 10 mg weekly 2.5 mg daily 5 daily 5 mg daily 6.25 mg daily 6.5 mg daily 10 daily 10 mg daily 10 mg one time 12 mg daily 12.5 daily 12.5 mg daily 13 mg daily 15 mg daily 18.75 mg daily 19 mg daily 20 mg daily 22.5 mg daily 25 mg daily 50 mg daily 80 mg daily 200 mg daily 543543 mg daily
  2 Number of Patients: 2 5 Number of Patients: 5 149 Number of Patients: 149 1 Number of Patients: 1 2 Number of Patients: 2 26 Number of Patients: 26 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 68 Number of Patients: 68 11 Number of Patients: 11 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 8 Number of Patients: 8 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 6 Number of Patients: 6 1 Number of Patients: 1 173 Number of Patients: 173 34 Number of Patients: 34 3 Number of Patients: 3 2 Number of Patients: 2 497 Number of Patients: 497 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 136 Number of Patients: 136 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 21 Number of Patients: 21 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Zolpidem (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
93 32% Did not seem to work: 32%
Side effects too severe
80 27% Side effects too severe: 27%
Doctor's advice
68 23% Doctor's advice: 23%
Other
66 22% Other: 22%
Expense
21 7% Expense: 7%
Course of treatment ended
16 5% Course of treatment ended: 5%
Personal research
13 4% Personal research: 4%
Not indicated
10 3% Not indicated: 3%
Change in health plan coverage
4 1% Change in health plan coverage: 1%

See all 280 patients who’ve stopped taking Zolpidem

Currently Taking Zolpidem

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Zolpidem

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
186 62%
Usually
72 24%
Sometimes
31 10%
Never
9 3%

Burden

Difficulty being on treatment

Very
13 4%
Somewhat
23 8%
A little
45 15%
Not at all
217 73%

Cost

Paid out of pocket

$200+
1 0%
$100-199
2 1%
$50-99
13 4%
$25-49
40 13%
< $25
159 53%

See more information, including instructions, precautions, side effects, and interactions.

Report created on March 21, 2010.